UCSF Navigation Bar

UCSF Departments of Pathology & Laboratory Medicine Home Page

Lab Manual for UCSF Clinical Laboratories

Lab Manual for SFGH

Internal Resources

Z. Laura Tabatabai, MD

Research and Clinical Interests

My clinical interests are primarily in fine needle aspiration biopsy and exfoliative cytology and in evaluating patients in the FNA clinic. I am also involved in general surgical and genitourinary pathology. My primary research interests include the areas of cytology and genitourinary pathology. I collaborate with the Department of Urology to investigate epigenetic alterations in cancers of the genitourinary tract and with the Department of Radiology to investigate the role of MR spectroscopic and clinical MR imaging in the detection of prostate and kidney cancers as it relates to diagnosis, treatment, and follow-up of disease.

Selected Publications

  • Hirata H, Ueno K, Nakajima K, Tabatabai ZL, Hinoda Y, Ishii N, Dahiya R. Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells. Br J Cancer. 108(10):2070-8, 2013
  • Zhang VY, Westphalen A, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J. The role of metabolic imaging in radiation therapy of prostate cancer. NMR Biomed. 2013
  • Ueno K, Hirata H, Majid S, Yamamura S, Shahryari V, Tabatabai ZL, Hinoda Y, Dahiya R. Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by down-regulating RhoC and FZD4. Mol Cancer Ther. 11(1):244-253, 2012
  • Keshari KR, Tsachres H, Iman R, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J. Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment. NMR Biomed. 24(6):691-699, 2011
  • Ueno K, Hirata H, Shahryari V, Chen Y, Zaman MS, Singh K, Tabatabai ZL, Hinoda Y, Dahiya R.Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma. Br J Cancer 104(2):308-315, 2011
  • Saini S, Majid S, Yamamura S, Tabatabai ZL, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R. Regulatory role of miR-203 in prostate cancer progression and metastasis. Clin Cancer Res. 17(16):5287-5298, 2011
  • Hirata H, Hinoda Y, Nakajima K, Kikuno N, Yamamura S, Kawakami K, Suehiro Y, Tabatabai ZL, Ishii N, Dahiya R. Wnt antagonist gene polymorphisms and renal cancer. Cancer 115(19):4488-4503, 2009
  • Hirata H, Hinoda Y, Nakajima K, Kikuno N, Suehiro Y, Tabatabai ZL, Ishii N, Dahiya R.The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer. J Urol 182(2):721-727, 2009
  • Hirata H, Hinoda Y, Kikuno N, Suehiro Y, Shahryari V, Ahmad AE, Tabatabai ZL, Igawa M, Dahiya R. Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy. J Urol 181(4):1907-1912, 2009

Additional Information

  • Professor of Clinical Pathology, UCSF
  • Director of Cytopathology, SFVAMC
  • Pathology
  • Surgical Pathology
  • Cytopathology
  • FNA Clinic

Specialty Area

  • Cytopathology
  • Surgical Pathology
  • Genitourinary Pathology

Contact Information

  • Department of Pathology, 113B
  • 4150 Clement Street
  • San Francisco, CA 94121

Hospital Affiliation(s)

  • Moffitt-Long Hospital
  • SFVAMC Hospital
UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center